| Metal-based nanoparticles as antimicrobial agents: an overview E Sánchez-López, D Gomes, G Esteruelas, L Bonilla, AL Lopez-Machado, ... Nanomaterials 10 (2), 292, 2020 | 967 | 2020 |
| Current research therapeutic strategies for Alzheimer’s disease treatment J Folch, D Petrov, M Ettcheto, S Abad, E Sánchez-López, ML García, ... Neural plasticity 2016, 2016 | 325 | 2016 |
| Dietary resveratrol prevents Alzheimer’s markers and increases life span in SAMP8 D Porquet, G Casadesús, S Bayod, A Vicente, AM Canudas, J Vilaplana, ... Age 35, 1851-1865, 2013 | 275 | 2013 |
| The sirtuin pathway in ageing and Alzheimer disease: mechanistic and therapeutic considerations DJ Bonda, H Lee, A Camins, M Pallàs, G Casadesus, MA Smith, X Zhu The Lancet Neurology 10 (3), 275-279, 2011 | 265 | 2011 |
| Low-dose pterostilbene, but not resveratrol, is a potent neuromodulator in aging and Alzheimer's disease J Chang, A Rimando, M Pallas, A Camins, D Porquet, J Reeves, ... Neurobiology of aging 33 (9), 2062-2071, 2012 | 250 | 2012 |
| Novel donepezil-based inhibitors of acetyl-and butyrylcholinesterase and acetylcholinesterase-induced β-amyloid aggregation P Camps, X Formosa, C Galdeano, T Gómez, D Munoz-Torrero, ... Journal of medicinal chemistry 51 (12), 3588-3598, 2008 | 240 | 2008 |
| Memantine for the treatment of dementia: a review on its current and future applications J Folch, O Busquets, M Ettcheto, E Sánchez-López, RD Castro-Torres, ... Journal of Alzheimer's Disease 62 (3), 1223-1240, 2018 | 235 | 2018 |
| Dual-drug loaded nanoparticles of Epigallocatechin-3-gallate (EGCG)/Ascorbic acid enhance therapeutic efficacy of EGCG in a APPswe/PS1dE9 Alzheimer's disease mice model A Cano, M Ettcheto, JH Chang, E Barroso, M Espina, BA Kühne, ... Journal of Controlled Release 301, 62-75, 2019 | 234 | 2019 |
| From aging to Alzheimer's disease: unveiling “the switch” with the senescence-accelerated mouse model (SAMP8) M Pallas, A Camins, MA Smith, G Perry, H Lee, G Casadesus Journal of Alzheimer's Disease 15 (4), 615-624, 2008 | 224 | 2008 |
| Memantine loaded PLGA PEGylated nanoparticles for Alzheimer’s disease: In vitro and in vivo characterization E Sánchez-López, M Ettcheto, MA Egea, M Espina, A Cano, AC Calpena, ... Journal of nanobiotechnology 16, 1-16, 2018 | 207 | 2018 |
| Protective effects of C-phycocyanin against kainic acid-induced neuronal damage in rat hippocampus V Rimbau, A Camins, C Romay, R González, M Pallàs Neuroscience letters 276 (2), 75-78, 1999 | 207 | 1999 |
| Resveratrol and neurodegenerative diseases: activation of SIRT1 as the potential pathway towards neuroprotection M Pallàs, G Casadesús, MA Smith, A Coto-Montes, C Pelegri, J Vilaplana, ... Current neurovascular research 6 (1), 70-81, 2009 | 206 | 2009 |
| Early alterations in energy metabolism in the hippocampus of APPswe/PS1dE9 mouse model of Alzheimer's disease I Pedrós, D Petrov, M Allgaier, F Sureda, E Barroso, C Beas-Zarate, ... Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease 1842 (9 …, 2014 | 201 | 2014 |
| Activation of nuclear factor-κB in the rat brain after transient focal ischemia C Gabriel, C Justicia, A Camins, AM Planas Molecular brain research 65 (1), 61-69, 1999 | 180 | 1999 |
| Current applications of nanoemulsions in cancer therapeutics E Sánchez-López, M Guerra, J Dias-Ferreira, A Lopez-Machado, ... Nanomaterials 9 (6), 821, 2019 | 169 | 2019 |
| Different glial response to methamphetamine-and methylenedioxymethamphetamine-induced neurotoxicity D Pubill, AM Canudas, M Pallàs, A Camins, J Camarasa, E Escubedo Naunyn-Schmiedeberg's archives of pharmacology 367, 490-499, 2003 | 169 | 2003 |
| High-fat diet-induced deregulation of hippocampal insulin signaling and mitochondrial homeostasis deficiences contribute to Alzheimer disease pathology in rodents D Petrov, I Pedrós, G Artiach, FX Sureda, E Barroso, M Pallàs, ... Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease 1852 (9 …, 2015 | 168 | 2015 |
| Involvement of calpain activation in neurodegenerative processes A Camins, E Verdaguer, J Folch, M Pallàs CNS drug reviews 12 (2), 135-148, 2006 | 168 | 2006 |
| Excitotoxicity in the pathogenesis of neurological and psychiatric disorders: Therapeutic implications J Olloquequi, E Cornejo-Córdova, E Verdaguer, FX Soriano, O Binvignat, ... Journal of psychopharmacology 32 (3), 265-275, 2018 | 166 | 2018 |
| Neuroprotective role of trans-resveratrol in a murine model of familial Alzheimer's disease D Porquet, C Grinan-Ferre, I Ferrer, A Camins, C Sanfeliu, J Del Valle, ... Journal of Alzheimer's disease 42 (4), 1209-1220, 2014 | 166 | 2014 |
Mercè PallàsProfessor of Pharmacology. University of Barcelona. Faculty of PharmacyEmail confirmado em ub.edu
